Prospects for ending the HIV epidemic among persons who inject drugs in Haiphong, Vietnam

被引:25
作者
Des Jarlais, Don C. [1 ]
Duong Thi Huong [2 ]
Khuat Thi Hai Oanh [3 ]
Minh Khue Pham [2 ]
Hoang Thi Giang [2 ]
Nham Thi Tuyet Thanh [3 ]
Arasteh, Kamyar [1 ]
Feelemyer, Jonathan [1 ]
Hammett, Theodore [4 ]
Peries, Marianne [5 ]
Michel, Laurent [6 ]
Vinh Vu Hai [7 ]
Roustide, Marie Jauffret [8 ]
Moles, Jean-Pierre [5 ]
Laureillard, Didier [5 ,9 ]
Nagot, Nicolas [5 ]
机构
[1] Icahn Sch Med Mt Sinai, New York, NY 10006 USA
[2] Hai Phong Univ Med & Pharm, Hai Phong, Vietnam
[3] Supporting Community Dev Initiat, Hanoi, Vietnam
[4] Abt Associates Inc, Cambridge, MA USA
[5] Univ Montpellier, Etab Francais Sang, INSERM, U1058, F-34059 Montpellier, France
[6] Red Cross, Pierre Nicole Ctr, Paris, France
[7] Viet Tiep Hosp, Dept Infect Dis, Hai Phong, Vietnam
[8] INSERM, Paris, France
[9] Caremeau Univ Hosp, Dept Infect Dis, Nimes, France
关键词
HIV; Persons who inject drugs (PWID); Vietnam; Respondent driven sampling (RDS); Sex workers; Men who have sex with men (MSM); HUMAN-IMMUNODEFICIENCY-VIRUS; MIDDLE-INCOME COUNTRIES; NEW-YORK-CITY; HARM REDUCTION; USERS; PROGRAMS; PEOPLE; PREVENTION; DETENTION; POLICY;
D O I
10.1016/j.drugpo.2016.02.021
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: To examine the prospects for "ending the HIV epidemic" among persons who inject drugs (PWID) in Haiphong, Vietnam. Reaching an incidence of <0.5/100 person-years at risk (PY) was used as an operational definition for "ending the epidemic." Methods: A respondent driven sampling study of 603 PWID was conducted from September to October 2014. Current heroin use (verified with urine testing and marks of injection) was an eligibility requirement. A structured questionnaire was administered by trained interviewers to obtain demographic, drug use, and risk behavior data; HIV counseling and testing and HCV testing was also conducted. Two methods (by assuming all new injectors were HIV negative at first injection and by slope of prevalence by years injecting) were used for estimating HIV among persons injecting for <5 years ("new injectors"). Comparisons were made to the HIV epidemic among PWID in New York City and modeling of the HIV epidemic in Can Tho province. Results: HIV prevalence was 25% in 2014, down from 68% in 2006 and 48% in 2009; overall HCV prevalence in the study was 67%. Among HIV seropositive PWID, 33% reported receiving antiretroviral treatment. The great majority (83%) of subjects reported pharmacies as their primary source of needles and syringes and self-reported receptive and distributive syringe sharing were quite low (<6%). Estimating HIV incidence among non-MSM male new injectors with the assumption that all were HIV negative at first injection gave a rate of 1.2/100 person-years (95% CI -0.24, 3.4). Estimating HIV incidence by the slope of prevalence by years injecting gave a rate of 0.8/100 person-years at risk (95% CI -0.9, 2.5). Conclusions: The current HIV epidemic among PWID in Haiphong is in a declining phase, but estimated incidence among non-MSM new injectors is approximately 1/100 person-years and there is a substantial gap in provision of ART for HIV seropositives. Scaling up interventions, particularly HIV counseling and testing and antiretroviral treatment for all seropositive PWID, should accelerate the decline. Ending the epidemic is an attainable public health goal. (C) 2016 Elsevier B.V. All rights reserved.
引用
收藏
页码:50 / 56
页数:7
相关论文
共 34 条
[1]   Drug injecting and HIV risk among injecting drug users in Hai Phong, Vietnam: a qualitative analysis [J].
Ahmed, Tanvir ;
Thanh Nguyen Long ;
Phan Thi Huong ;
Stewart, Donald Edwin .
BMC PUBLIC HEALTH, 2015, 15
[2]   Compulsory drug detention in East and Southeast Asia: Evolving government, UN and donor responses [J].
Amon, Joseph J. ;
Pearshouse, Richard ;
Cohen, Jane E. ;
Schleifer, Rebecca .
INTERNATIONAL JOURNAL OF DRUG POLICY, 2014, 25 (01) :13-20
[3]  
Amon JJ, 2013, HEALTH HUM RIGHTS, V15, P124
[4]  
[Anonymous], 2013, WORLD DRUG REP 2013
[5]  
[Anonymous], REC EXP ANT THER ALL
[6]  
[Anonymous], 2015, MAX TREATM PREV POT
[7]  
[Anonymous], RESPONDENT DRIVEN SA
[8]   HIV incidence among injection drug users in New York City, 1992-1997: Evidence for a declining epidemic [J].
Des Jarlais, DC ;
Marmor, M ;
Friedmann, P ;
Titus, S ;
Aviles, E ;
Deren, S ;
Torian, L ;
Glebatis, D ;
Murrill, C ;
Monterroso, E ;
Friedman, SR .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2000, 90 (03) :352-359
[9]   Consistent Estimates of Very Low HIV Incidence Among People Who Inject Drugs: New York City, 2005-2014 [J].
Des Jarlais, Don C. ;
Arasteh, Kamyar ;
McKnight, Courtney ;
Feelemyer, Jonathan ;
Campbell, Aimee N. C. ;
Tross, Susan ;
Smith, Lou ;
Cooper, Hannah L. F. ;
Hagan, Holly ;
Perlman, David .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2016, 106 (03) :503-508
[10]   High coverage needle/syringe programs for people who inject drugs in low and middle income countries: a systematic review [J].
Des Jarlais, Don C. ;
Feelemyer, Jonathan P. ;
Modi, Shilpa N. ;
Abu Abdul-Quader ;
Hagan, Holly .
BMC PUBLIC HEALTH, 2013, 13 :53